MMed (Neurological Surgery), Faculty of Health Sciences, University of the Witwatersrand / The purpose of this retrospective study was to review the patient records with regard to demographics, clinical presentation, laboratory tests, histology, management and outcome of patients presenting at Chris Hani Baragwanath and Charlotte Maxeke Johannesburg Academic Hospitals with pituitary adenomas over a ten year period from 1999 to 2008. Methods: The patient records accessed included discharge summaries, admission files, laboratory results, imaging films, ophthalmology records and histology results. The information gathered was analyzed in terms of the above mentioned parameters. Results: There was a slight female preponderance at 55% vs 45% males, with a mean age of 46 years. 89% of the study population was of a Black race, reflecting the actual demographic pattern of the hospital population rather than the tumour prevalence in Blacks. Visual disturbance (94%) and headaches (75%) were very common and reflected the late presentation of our patients. Features of hypopituitarism and hyperprolactinaemia were the commonest of hormone imbalances at 33% and 39% respectively. 80% of the total study population was treated by transphenoidal surgery. The remainder was mainly prolactinomas treated with oral dopamine agonists and those who refused surgery. 2% required transcranial approach while 13% received further radiation therapy. Outcome was good with regard to improvement or resolution of headaches at 65%, while improvement in visual acuity and field defects were less satisfactory, with 51% showing improvement, and 44% remaining the same post operatively. This underlies the concern regarding late presentation of our patients with irreversible visual impairment. v 100% of prolactinomas showed improvement or normalization of the prolactin levels with bromocriptine or carbegoline, however, of those who presented with hypopituitarism 43% required post operative hormone replacement in the form of cortisol acetate or prednisone and thyroxin. Conclusion: Our patient demographics are similar to those published elsewhere, however, of great concern is the late presentation with irreversible visual impairment and hormonal imbalance. Government and community education, in a multidisciplinary approach is required to improve our situation.

No description available.

No description available.

No description available.

No description available.

Submitted by Rosivalda Pereira (mrs.pereira@ufma.br) on 2017-05-17T21:14:35Z No. of bitstreams: 1 AnaGiseliaNascimento.pdf: 3146962 bytes, checksum: 2e04b37893415a3b55c8a3bcd2cf19b9 (MD5) / Made available in DSpace on 2017-05-17T21:14:35Z (GMT). No. of bitstreams: 1 AnaGiseliaNascimento.pdf: 3146962 bytes, checksum: 2e04b37893415a3b55c8a3bcd2cf19b9 (MD5) Previous issue date: 2016-09-30 / Pituitary adenomas represent 10-15% of all intracranial tumors with an incidence of 1/1000 of the population. They are considered benign and mostly slow growth. Despite this, about 35% may present with invasion of parasellar compartments and a significant number have a clinically aggressive behavior with early recurrence during follow-up, despite surgery and other therapeutic approaches. Such aggressive tumors should be identified early in order to provide a more incisive treatment and / or a strict clinical and radiological follow-up, with prompt djunctive therapy institution in persistence or recurrence of these tumors. Despite these considerations, to date, no clinical, radiological and histological marker predicting such behavior has been established. This study aims to reassess the role of Ki-67 through an improved immunohistochemical technique for the expression of these antigens and correlate it to demographic and clinicopathological parameters of pituitary adenomas. This is a crosssectional study conducted from November 2015 to August 2016 were used pituitary adenoma tissue from 62 patients from the Endocrinology Service of the University of the Federal University of Maranhão Hospital. For evaluation of adenomas of medical records data were analyzed, namely: clinical and serum levels of related hormones as well as magnetic resonance imaging of the pituitary gland. To analyze the expression of Ki-67 was performed immunohistochemical technique using the anti-human monoclonal primary antibody, expressed by the percentage of labeled nuclei in the form of labeling index Ki-67. In our sample of 62 patients, 31 patients were female (50%) with a mean age at surgery of 46.2 (± 13.3) years, ranging from 16 to 73 years. Ki-67 index, as well as their median had to be higher in females, with p = 0.04 and p = 0.02, respectively. There was no predominance of expression and Ki-67 index with respect to age and diagnosis. Adenomas giant had higher median Ki-67 with respect to non giants with p = 0.04, but there was no correlation of Ki-67 with tumor invasion. The pituitary adenomas previously submitted to specific pharmacotherapy showed expression of Ki-67 lower, however, only when the somatotropinomas were analyzed separately, there was statistically significant with p = .0,03. The Ki-67 antigen, a marker of tumor proliferative activity, play an important role in pituitary adenomas. In conjunction with other biomarkers such as tumor invasion, large volume adenoma the initial presentation of patients and / or rapid tumor growth rate documentation can lead to identification of patients which show an aggressive clinical behavior, in order to conduct a multimodal therapeutic approach more effective or more strict postoperative follow-up. / Adenomas hipofisários representam de 10-15% de todas as neoplasias intracranianas com prevalência de um caso para 1000 habitantes. Apresentam grande variação de comportamento clínico, sendo a maioria de crescimento indolente, enquanto cerca de 35% podem ser invasivos e um pequeno grupo francamente agressivo. Até o presente momento, não há um biomarcador que possa predizer seu comportamento de forma confiável, o que possibilitaria uma terapia adjuvante mais agressiva ou um seguimento clínico mais rigoroso. O objetivo desse estudo foi avaliar a expressão e o índice do marcador imuno-histoquímico de proliferação celular, antígeno Ki-67 em adenomas hipofisários e correlacioná-lo a parâmetros demográficos e clínico-patológicos, visando definir sua relevância prognóstica. Trata-se de um estudo transversal realizado no período de novembro de 2015 a agosto de 2016. Foram utilizados tecidos de adenomas hipofisários de 62 pacientes oriundos do Serviço de Endocrinologia do Hospital Universitário da Universidade Federal do Maranhão. Para avaliação dos adenomas foram analisados dados dos prontuários, a saber: avaliação clínica e dosagens séricas de hormônios relacionados, assim como ressonância nuclear magnética de hipófise. Para analisar a expressão do Ki-67, foi realizada a técnica de imuno-histoquimica utilizando-se o anticorpo primário monoclonal anti-humano expressado pela percentagem de núcleos imunopositivos sob forma de índice de marcação de Ki-67. Na amostra de 62 pacientes, 31 pacientes foram do sexo feminino (50%) com a média de idade à época da cirurgia de 46,2 (±13,3) anos, variando de 16 a 73 anos. O antígeno Ki-67 apresentou expressão em 37 (59,7%) pacientes, variando o seu índice de 0,1% a 2,4%. O índice Ki-67, assim como a sua mediana apresentaram-se mais elevados no sexo feminino com p=0,04 e p=0,02, respectivamente. Não houve predominância da expressão e do índice de Ki-67 com relação a idade e diagnóstico. Adenomas gigantes apresentaram mediana de Ki-67 mais elevada com relação aos não gigantes com valor de p=0,04, mas não houve qualquer correlação de Ki-67 com a invasão tumoral. Os adenomas hipofisários previamente submetidos à farmacoterapia específica apresentaram expressão de Ki-67 mais baixos, no entanto, somente quando os somatotropinomas foram analisados de forma isolada, houve significância estatística com p=0,03. O antígeno Ki-67, marcador de atividade proliferativa tumoral, tem papel relevante em adenomas hipofisários. Em conjunto com outros biomarcadores, como invasão tumoral, grande volume do adenoma à apresentação inicial dos pacientes e/ou documentação de rápida velocidade de crescimento do tumor, pode levar a identificação de pacientes que demonstrem um comportamento clínico agressivo, de forma a conduzir a uma abordagem terapêutica multimodal mais efetiva ou a um seguimento pós operatório mais estrito.

Colorectal polyp prevention trials (PPTs) are randomized, placebo-controlled clinical trials that evaluate some chemo-preventive agent and include participants who will be followed for at least 3 years to compare the recurrence rates (counts) of adenomas. A large proportion of zero counts will likely be observed in both groups at the end of the observation period. Poisson general linear models (GLMs) are usually employed for estimation of recurrence in PPTs. Other models, including the negative binomial (NB2), zero-inflated Poisson (ZIP), and zero-inflated negative binomial (ZINB) may be better suited to handle zero-inflation or other forms of overdispersion that are common in count data. A model selection paradigm that determines a statistical approach for choosing the best fitting model for recurrence data is described. An example using a subset from a large Phase III clinical trial indicated that the ZINB model was the best fitting model for the data.

Pour avoir une parfaite compréhension dune maladie, il est nécessaire den connaitre la fréquence, la symptomatologie et les causes dapparition. Dans le cas des adénomes hypophysaires, les données de la littérature concernant lépidémiologie de ces tumeurs sont contradictoires certaines études suggérant une haute prévalence, et dautres affirmant quelles sont plutôt rares. En parallèle, la compréhension de la physiopathologie des tumeurs endocrines telles que les adénomes hypophysaires a fait un bond en avant avec lavènement des techniques de biologie moléculaire. Pourtant, leur physiopathologie reste encore très floue. Le fait de se concentrer sur les causes familiales permet dapprocher plus efficacement les causes des tumeurs endocrines. Concernant les adénomes hypophysaires, mis à part les Néoplasies endocriniennes multiples de type I (MEN1) et le Complexe de Carney (CNC), le domaine des adénomes hypophysaires familiaux est peu compris. En effet, mise à part lacromégalie familiale, il ny a eu aucune étude sur dautres types dadénomes hypophysaires entrant dans le cadre familial. Les buts du travail contenu dans cette thèse étaient de décrire des aspects épidémiologiques et génétiques des adénomes hypophysaires. Tout dabord, nous avons étudié la discordance entre les taux de prévalence dadénomes hypophysaires provenant détudes radiologiques/autopsiques (les incidentalomes étant très fréquents) et dautre part ceux provenant de registres de cancers et plus rarement de données de population. Une étude intensive et complète de la prévalence des adénomes hypophysaires a été réalisée dans 3 régions géographiquement parfaitement délimitées dans la province de Liège. Dans cette étude qui a concerné une population de plus de 70 000 habitants, les adénomes hypophysaires diagnostiqués lont été en collaboration avec toute la communauté médicale de ces régions. Les données démographiques, cliniques, hormonales, radiologiques et pathologiques de tous les patients ont été confirmées de façon indépendante. A une date fixe, nous avons montré que les adénomes hypophysaires diagnostiqués suite à des symptômes cliniques surviennent avec une prévalence de 1 cas par 1064 habitants résidants dans les limites géographiques déterminées pour cette étude. Ces résultats montrent que la prévalence des adénomes hypophysaires évidents sur le plan clinique est de 3.5 à 5 fois plus haute que les estimations précédentes se rapportant à des populations ou des registres. Cela suggère que les adénomes hypophysaires significatifs sur le plan clinique surviennent assez fréquemment dans la pratique de tous les jours et ceci peut avoir des implications importantes sur la distribution des ressources de santé. Une étude épidémiologique internationale appliquant la même méthodologie est actuellement en cours. Létude des adénomes hypophysaires familiaux en-dehors du contexte de la polyendocrinopathie de type I ou du Complexe de Carney constitue la deuxième partie de ce travail. Jusquà présent, seule lacromégalie familiale avait été rapportée dans la littérature. Nous avons réalisé une étude internationale pour démontrer que tous les types dadénomes hypophysaires pouvaient survenir dans le cadre dune pathologie familiale différente de la polyendocrinopathie de type I et du complexe de Carney. La suspicion de cette pathologie est née à Liège au cours de la dernière décennie. Cette étude a démontré que les adénomes hypophysaires familiaux isolés (Familial Isolated Pituitary Adenoma ou FIPA) constituent 2% des adénomes hypophysaires et 64 familles FIPA ont été caractérisées cliniquement. Cette étude a démontré pour la première fois que tous les phénotypes dadénomes hypophysaires peuvent survenir dans les mêmes familles. Quelques familles montrent seulement un phénotype parmi les membres atteints (familles FIPA homogènes) et dautres familles montrent différents types de tumeurs chez les patients atteints (famille FIPA hétérogène). Dans les familles FIPA, les adénomes hypophysaires étaient plus agressifs et tendaient à survenir à un âge plus jeune que dans les cas sporadiques. Les familles FIPA montrent une grande proximité familiale entre les membres atteints suggérant un mode dominant de transmission. Les études ultérieures ont été réalisées sur les aspects génétiques et anatomo-pathologiques des adénomes hypophysaires et particulièrement ceux qui survenaient dans le contexte FIPA. La découverte dun gène nouveau aryl hydrocarbon receptor interacting protein (AIP), dont quelques mutations ont été associées avec des adénomes hypophysaires nous a conduit à entreprendre la première étude génétique dans les FIPA. Des mutations AIP ont été découvertes dans 15 % des familles et 50% des familles homogènes dacromégales dans le contexte FIPA. Ceci suggère que dautres gènes peuvent également être responsables du contexte FIPA. Dans les familles FIPA qui portent la mutation AIP, les tumeurs étaient plus importantes et survenaient à un âge plus jeune que dans les familles FIPA sans mutation AIP. Neuf nouvelles mutations AIP ont été identifiées, dont la majorité permet de prédire la perte du ligand ou de la région de AIP qui interagit avec son récepteur. Une mutation AIP dans les FIPA était associée avec différents types dadénomes hypophysaires incluant acromégalie, prolactinomes, adénomes mixtes à GH-prolactine et adénomes nonsécrétants. Nous avons également observé que la même mutation AIP pouvait être responsable de différents phénotypes dans 2 familles FIPA différentes. Un suivi détaillé dune famille FIPA avec mutation AIP a permis de montrer pour la première fois quune anomalie endocrinienne différente dune tumeur hypophysaire pouvait survenir chez des porteurs de mutation AIP (élévation de lIGF1). Une analyse détaillée de lADN germinal et somatique provenant dun grand groupe international européen dadénomes hypophysaires sporadiques (non familiaux) a montré que les mutations AIP surviennent rarement dans cette condition. En conclusion : Le travail entrepris a apporté une nouvelle compréhension de la vraie prévalence des adénomes hypophysaires diagnostiqués de façon clinique dans une population et il a permis de codifier et de caractériser le désordre FIPA, une nouvelle entité clinique qui représente une aire de recherche potentielle pour des études cliniques et génétiques impliquant la fonction de AIP et dautres gènes non encore identifiés. To have a full understanding of a disease, it is necessary to at least know how frequently it occurs, its clinical features and by what means it is caused. In the case of pituitary adenomas, data in the literature on the epidemiology of these tumors is conflicting, with some studies suggesting a high frequency, others that they occur rarely in the clinical setting. In parallel, the understanding of the pathophysiology of endocrine tumors like pituitary adenomas has advanced greatly with the advent of molecular genetic techniques. However, much remains unclear regarding pathophysiology. A valuable avenue for studying the causes of endocrine tumors has been to focus on the familial setting. With respect to pituitary adenomas, apart from multiple endocrine neoplasia type 1 (MEN1) and Carney complex (CNC), the field of familial pituitary tumors is poorly understood. Indeed, apart from familial acromegaly, there have been virtually no studies on other pituitary adenomas occurring in the familial setting. The aims of the work described in this thesis were based on addressing aspects of the epidemiology and genetics of pituitary tumors. Firstly, the disconnect between the prevalence rates for pituitary adenomas from autopsy/radiology studies (incidentalomas being very common) and cancer registries/population data (rare) was studied. An intensive, comprehensive, case-finding study of the prevalence of pituitary adenomas was performed in three tightly-defined geographical areas in the Province of Liège. In this study, which involved a population of more than 70,000 people, diagnosed pituitary adenomas were sought in collaboration with the entire group of community medical practitioners in the study areas, and the demographics and clinical, hormonal, radiological and pathological features of all patients were confirmed independently. On a fixed date, it was found that clinically diagnosed pituitary adenomas occurred with a prevalence of 1 case per 1064 individuals residing within the geographic boundaries of the study. These results report a clinical prevalence of pituitary adenomas that is 3.5 to 5 times higher than previous population/registry estimates. It suggests that clinically relevant pituitary adenomas occur frequently in the everyday clinical setting, which may have important implications for health resource allocations. Also, it is possible to undertake detailed, comprehensive, crosssectional epidemiological studies in well-defined geographic areas, and this methodology can be applied internationally Studying the familial occurrence of pituitary adenomas outside of MEN1 and CNC was the next aim of the work described. Up to this time, only the familial occurrence of acromegaly had been reported with any frequency in the literature. An international study was undertaken to assess whether isolated pituitary adenomas of all types could occur in the familial setting, a suspicion raised in Liège over the past decade. This study demonstrated that familial isolated pituitary adenomas (FIPA) occur in about 2% of pituitary adenoma populations, and 64 FIPA families were characterized clinically. The study demonstrated for the first time that all phenotypes of pituitary adenomas can occur together in families; some families exhibit only one phenotype among affected members (homogeneous FIPA kindreds), others have multiple tumor types among affected family members (heterogeneous FIPA). In FIPA families, pituitary tumors were more aggressive and tended to occur at a younger age than sporadic pituitary adenomas. FIPA families display a high degree of familiality, suggesting a dominant mode of inheritance. Subsequent studies were performed on the genetic and pathological features of pituitary adenomas, particularly those occurring as FIPA. The discovery of a novel gene, aryl hydrocarbon receptor interacting protein ( AIP), mutations in which were associated with isolated pituitary adenomas, led us to undertake the first such genetic studies in FIPA. AIP mutations account for a minority (15%) of FIPA families and 50% of familial acromegaly kindreds in FIPA. This suggests that other genetic causes for FIPA also exist. In AIP mutation carrying FIPA families, tumors were larger and had a younger age at diagnosis than non- AIP mutated FIPA kindreds. A series of 9 novel AIP mutations were identified, the majority of which led to predicted loss of vital ligand and receptor interacting regions of the AIP protein. AIP mutations in FIPA were associated with multiple pituitary adenoma types, including acromegaly, prolactinomas, mixed growth hormone/prolactin secreting adenomas and non-secreting tumors. It was also found that the same AIP mutation was responsible for different pituitary adenoma types in two separate FIPA families. A detailed follow-up study of an individual FIPA kindred with an AIP mutation found for the first time that non-pituitary tumor-associated endocrine abnormalities (elevated circulating insulin-like growth factor-1) occur in AIP mutation carriers. A detailed analysis of germline and somatic DNA from a large international European cohort of sporadic (non-familial) pituitary adenoma cases showed that AIP mutations occur rarely in this setting. In conclusion, the work undertaken has provided new understanding of the true prevalence of clinically-relevant pituitary adenomas in the population, in addition to codifying and characterizing FIPA, a new clinical entity that represents a potentially valuable area for genetic and clinical studies involving the function of AIP and other as yet unidentified associated genetic causes.

O manejo clínico dos pacientes com pólipos colorretais é principalmente baseado na histologia das lesões removidas. Em conseqüência, o diagnóstico histológico tem um papel muito importante na decisão terapêutica e a uniformidade de interpretação dos diferentes laudos de patologia é essencial. Apesar destas relevantes implicações, poucos estudos existem avaliando a variabilidade interobservador na elucidação dessa doença e a concordância não é considerada satisfatória. Objetivo: avaliar a variabilidade interobservador no diagnóstico histológico dos pólipos colorretais. Metodologia: foram avaliados 230 pólipos colorretais no Serviço de Patologia do Hospital de Clínicas de Porto Alegre (HCPA). Quatro patologistas examinaram todas as lâminas de forma independente e “cega”, ou seja, sem conhecimento do diagnóstico elaborado pelo seu colega. As lesões colorretais foram classificadas em relação ao diagnóstico: pólipo e carcinoma invasivo e quanto ao tipo de pólipo: adenomatoso versus hiperplásico. Nos adenomas foi avaliado o tipo histológico (tubular, túbulo-viloso e viloso) e o grau de displasia (baixo e alto grau). Resultados: o Kappa médio, em relação ao tipo de lesão, foi de 0,794, considerado moderado. Quanto ao tipo de pólipo, o Kappa médio foi 0,852, ou seja, uma ótima concordância. Em relação aos adenomas, no que se refere ao tipo histológico, obteve-se um Kappa médio, fraco de 0,291, e na avaliação do grau de displasia o Kappa médio foi regular com valor de 0,420. Conclusão: o índice de concordância, entre os quatro observadores foi considerado de moderado a ótimo no tipo de lesão e de pólipo, porém a variabilidade foi grande na avaliação dos adenomas, tanto no que concerne ao tipo histológico quanto ao grau de displasia com um kappa de fraco a regular. / The clinical management of patients with colorectal polyps is mainly based on the histology of the removed lesions. Therefore, the histological diagnosis has a very important role in deciding the treatment and the uniform interpretation of the different pathology reports is essential. In spite of these relevant implications, there are only very few studies assessing the interobserver variability in such diagnosis and the concordance of reports among different examiners is not considered satisfactory. Objective: to assess interobserver variability in the pathology reports in the diagnosis of colorectal polyps. Method: at the Department of Pathology of HCPA [Hospital de Clínicas de Porto Alegre] 230 slides of colorectal polyps were examined by four independent pathologists “blindly”, that is, the diagnosis given by their colleagues was not known. Colorectal lesions were classified according to the diagnosis as polyp or invasive cancer and to the polyp type (adenomatous or hyperplasic). The histological type of the adenomas (tubular, tubulovillous and villous) and the grade of dysplasia (high or low) were also assessed. Results: mean kappa of the type of lesion was 0.794, which is considered moderate. The mean kappa of 0.852 for the type of polyp is considered excellent concordance. Regarding the histology of adenomas, the mean kappa was 0.291, considered weak. The assessment of the degree of dysplasia showed a regular Kappa of 0.420. Conclusion: the concordance rate among the four pathologists was considered to be moderate to excellent for the type of lesion and of polyp but there was great variability in the assessment of adenomas both for the histological type and for dysplasia, showing a weak to regular kappa.

O manejo clínico dos pacientes com pólipos colorretais é principalmente baseado na histologia das lesões removidas. Em conseqüência, o diagnóstico histológico tem um papel muito importante na decisão terapêutica e a uniformidade de interpretação dos diferentes laudos de patologia é essencial. Apesar destas relevantes implicações, poucos estudos existem avaliando a variabilidade interobservador na elucidação dessa doença e a concordância não é considerada satisfatória. Objetivo: avaliar a variabilidade interobservador no diagnóstico histológico dos pólipos colorretais. Metodologia: foram avaliados 230 pólipos colorretais no Serviço de Patologia do Hospital de Clínicas de Porto Alegre (HCPA). Quatro patologistas examinaram todas as lâminas de forma independente e “cega”, ou seja, sem conhecimento do diagnóstico elaborado pelo seu colega. As lesões colorretais foram classificadas em relação ao diagnóstico: pólipo e carcinoma invasivo e quanto ao tipo de pólipo: adenomatoso versus hiperplásico. Nos adenomas foi avaliado o tipo histológico (tubular, túbulo-viloso e viloso) e o grau de displasia (baixo e alto grau). Resultados: o Kappa médio, em relação ao tipo de lesão, foi de 0,794, considerado moderado. Quanto ao tipo de pólipo, o Kappa médio foi 0,852, ou seja, uma ótima concordância. Em relação aos adenomas, no que se refere ao tipo histológico, obteve-se um Kappa médio, fraco de 0,291, e na avaliação do grau de displasia o Kappa médio foi regular com valor de 0,420. Conclusão: o índice de concordância, entre os quatro observadores foi considerado de moderado a ótimo no tipo de lesão e de pólipo, porém a variabilidade foi grande na avaliação dos adenomas, tanto no que concerne ao tipo histológico quanto ao grau de displasia com um kappa de fraco a regular. / The clinical management of patients with colorectal polyps is mainly based on the histology of the removed lesions. Therefore, the histological diagnosis has a very important role in deciding the treatment and the uniform interpretation of the different pathology reports is essential. In spite of these relevant implications, there are only very few studies assessing the interobserver variability in such diagnosis and the concordance of reports among different examiners is not considered satisfactory. Objective: to assess interobserver variability in the pathology reports in the diagnosis of colorectal polyps. Method: at the Department of Pathology of HCPA [Hospital de Clínicas de Porto Alegre] 230 slides of colorectal polyps were examined by four independent pathologists “blindly”, that is, the diagnosis given by their colleagues was not known. Colorectal lesions were classified according to the diagnosis as polyp or invasive cancer and to the polyp type (adenomatous or hyperplasic). The histological type of the adenomas (tubular, tubulovillous and villous) and the grade of dysplasia (high or low) were also assessed. Results: mean kappa of the type of lesion was 0.794, which is considered moderate. The mean kappa of 0.852 for the type of polyp is considered excellent concordance. Regarding the histology of adenomas, the mean kappa was 0.291, considered weak. The assessment of the degree of dysplasia showed a regular Kappa of 0.420. Conclusion: the concordance rate among the four pathologists was considered to be moderate to excellent for the type of lesion and of polyp but there was great variability in the assessment of adenomas both for the histological type and for dysplasia, showing a weak to regular kappa.